E. Galanis
Impact in
- Genetics top 5%
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
- Genetics 7
- Glioma Diagnosis and Treatment 7
- Virus-based gene therapy research 5
- Co-authors
- Joseph Rubin (2 shared papers)James L. Abbruzzese (2 shared papers)M. Jason Hatfield (2 shared papers)David H. Kirn (2 shared papers)Daniel Y. Sze (1 shared paper)James C. Andrews (1 shared paper)T. Reid (1 shared paper)Carla Heise (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Neuro-Oncology (2 papers)Clinical Cancer Research (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Current Opinion in Neurology (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
E. Galanis
17 papers receiving 637 citations
Peers
Comparison fields: 5 of 48
- Genetics 430
- Biotechnology 112
- Oncology 289
- Genetics 109
- Molecular Biology 340
Countries citing papers authored by E. Galanis
This map shows the geographic impact of E. Galanis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Galanis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Galanis more than expected).
Fields of papers citing papers by E. Galanis
This network shows the impact of papers produced by E. Galanis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Galanis. The network helps show where E. Galanis may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Galanis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints. | 2002 | 251 |
| 2 | 2001 | 185 | |
| 3 | 2010 | 56 | |
| 4 | 2012 | 37 | |
| 5 | 2015 | 26 | |
| 6 | 2016 | 26 | |
| 7 | 2015 | 18 | |
| 8 | 2018 | 14 | |
| 9 | 2007 | 13 | |
| 10 | 2008 | 7 | |
| 11 | 2010 | 5 | |
| 12 | 2005 | 5 | |
| 13 | 2019 | 5 | |
| 14 | 2011 | 3 | |
| 15 | 2009 | 2 | |
| 16 | 2011 | 2 | |
| 17 | 2004 | 1 |
About E. Galanis
E. Galanis is a scholar working on Molecular Biology, Genetics, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 656 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Virus-based gene therapy research (5 papers), Brain Metastases and Treatment (3 papers), Cancer Research and Treatments (3 papers), CAR-T cell therapy research (3 papers), Cancer Genomics and Diagnostics (2 papers), Meningioma and schwannoma management (2 papers) and Vascular Malformations Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (430 citations), Biotechnology (112 citations), Oncology (289 citations), Genetics (109 citations) and Molecular Biology (340 citations). E. Galanis has collaborated with scholars based in United States and Canada. Frequent co-authors include Joseph Rubin, James L. Abbruzzese, M. Jason Hatfield, David H. Kirn, Daniel Y. Sze, James C. Andrews, T. Reid, Carla Heise, Britta Randlev and M. J. Uprichard. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Current Opinion in Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.